Literature DB >> 10455015

Activation of TrkA by nerve growth factor upregulates expression of the cholinergic gene locus but attenuates the response to ciliary neurotrophic growth factor.

B Berse1, I Lopez-Coviella, J K Blusztajn.   

Abstract

Nerve growth factor (NGF) stimulates the expression of the cholinergic gene locus, which encodes choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), the proteins necessary for the synthesis and storage of the neurotransmitter acetylcholine (ACh). To determine whether this action of NGF is mediated by the p140TrkA NGF receptor (a member of the Trk tyrosine kinase family) we used a murine basal forebrain cholinergic cell line, SN56, stably transfected with rat trkA cDNA. Treatment of these transfectants with NGF activated mitogen-activated protein kinase and increased cytosolic free calcium concentrations, confirming the reconstitution of TrkA-mediated signalling pathways. The expression of ChAT and VAChT mRNA, as well as ACh content, were coordinately up-regulated by NGF in SN56-trkA transfectants. None of these responses occurred in the parental SN56 cells, which do not express endogenous TrkA, indicating that these actions of NGF required TrkA. We previously reported that ciliary neurotrophic factor (CNTF) upregulates the expression of ChAT and VAChT, as well as ACh production, in SN56 cells. The combined treatment of SN56-trkA cells with CNTF and NGF revealed a complex interaction of these factors in the regulation of cholinergic gene locus expression. At low concentrations of CNTF (<1 ng/ml), the upregulation of ACh synthesis evoked by these factors was additive. However, at higher concentrations of CNTF (>1 ng/ml), NGF attenuated the stimulatory effect of CNTF on ChAT and VAChT mRNA and ACh content. This attenuation was not due to interference with early steps of CNTF receptor signalling, as pre-treatment of SN56-trkA cells with NGF did not affect the nuclear translocation of the transcription factor, Stat3, evoked by CNTF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455015      PMCID: PMC1220465     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  69 in total

1.  Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene.

Authors:  J L Pongrac; R J Rylett
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

2.  A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat.

Authors:  T Debeir; H U Saragovi; A C Cuello
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine.

Authors:  S Bejanin; R Cervini; J Mallet; S Berrard
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

4.  Differential requirements for p21ras and protein kinase C in the regulation of neuronal gene expression by nerve growth factor and neurokines.

Authors:  J A Johnson; N M Nathanson
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

5.  NGF-induction of the expression of ChAT mRNA in PC12 cells and primary cultures of embryonic rat basal forebrain.

Authors:  J L Pongrac; R J Rylett
Journal:  Brain Res Mol Brain Res       Date:  1998-11-12

6.  Molecular cloning of a putative vesicular transporter for acetylcholine.

Authors:  A Roghani; J Feldman; S A Kohan; A Shirzadi; C B Gundersen; N Brecha; R H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

7.  TrkA antagonists decrease NGF-induced ChAT activity in vitro and modulate cholinergic synaptic number in vivo.

Authors:  T Debeir; H U Saragovi; A C Cuello
Journal:  J Physiol Paris       Date:  1998 Jun-Aug

8.  Leukemia inhibitory factor and NGF regulate signal transducers and activators of transcription activation in sympathetic ganglia: convergence of cytokine- and neurotrophin-signaling pathways.

Authors:  P Rajan; T Gearan; J S Fink
Journal:  Brain Res       Date:  1998-08-17       Impact factor: 3.252

9.  Decreased choline acetyltransferase activity in nerve growth factor-transgenic mice during brain development.

Authors:  A Faivre-Bauman; C Loudes; I Neveu; P Naveilhan; G Vantini; J Epelbaum; B Onteniente
Journal:  Neuroscience       Date:  1994-09       Impact factor: 3.590

10.  Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus.

Authors:  J D Erickson; H Varoqui; M K Schäfer; W Modi; M F Diebler; E Weihe; J Rand; L E Eiden; T I Bonner; T B Usdin
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

View more
  12 in total

1.  Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation.

Authors:  J M Conner; M A Darracq; J Roberts; M H Tuszynski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs.

Authors:  A Szutowicz; H Bielarczyk; S Gul; A Ronowska; T Pawełczyk; A Jankowska-Kulawy
Journal:  Metab Brain Dis       Date:  2006-05-25       Impact factor: 3.584

3.  Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway.

Authors:  Beata Madziar; Sonia Shah; Martina Brock; Rebecca Burke; Ignacio Lopez-Coviella; Ann-Christin Nickel; Esra Betul Cakal; Jan Krzysztof Blusztajn; Brygida Berse
Journal:  J Neurochem       Date:  2008-09-13       Impact factor: 5.372

4.  Nuclear choline acetyltransferase activates transcription of a high-affinity choline transporter.

Authors:  Akinori Matsuo; Jean-Pierre Bellier; Masaki Nishimura; Osamu Yasuhara; Naoaki Saito; Hiroshi Kimura
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

Review 5.  The cholinergic neuronal phenotype in Alzheimer's disease.

Authors:  J K Blusztajn; B Berse
Journal:  Metab Brain Dis       Date:  2000-03       Impact factor: 3.584

6.  BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons.

Authors:  Aletta C Schnitzler; Tiffany J Mellott; Ignacio Lopez-Coviella; Yvonne N Tallini; Michael I Kotlikoff; Maximillian T Follettie; Jan Krzysztof Blusztajn
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

7.  Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Authors:  Vinay Parikh; William M Howe; Ryan M Welchko; Sean X Naughton; Drew E D'Amore; Daniel H Han; Monika Deo; David L Turner; Martin Sarter
Journal:  Eur J Neurosci       Date:  2012-12-11       Impact factor: 3.386

8.  Abnormal chemosensory jump 6 is a positive transcriptional regulator of the cholinergic gene locus in Drosophila olfactory neurons.

Authors:  Mi-Heon Lee; Paul M Salvaterra
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 9.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  NGF is essential for hippocampal plasticity and learning.

Authors:  James M Conner; Kevin M Franks; Andrea K Titterness; Kyle Russell; David A Merrill; Brian R Christie; Terrence J Sejnowski; Mark H Tuszynski
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.